Orally Disintegrating Tablet (ODT)
TASCENSO ODT® (fingolimod) is the first MS treatment available as an easy-to-swallow, orally disintegrating tablet. It is the same proven fingolimod that you might be familiar with, but in a unique formulation, which could better suit your needs.1
Orally Disintegrating Tablet (ODT)
TASCENSO ODT is the first MS treatment available as an easy-to-swallow, orally disintegrating tablet. It is the same proven fingolimod that you might be familiar with, but in a unique formulation, which could better suit your needs.1
With TASCENSO ODT, it’s time for you.
Dissolves on the tongue in seconds
Can be taken with or without water
Can be taken with or without food
No special storage conditions are required, the product should be stored at room temperature (68°F to 77°F) and protected from moisture1
During a study of TASCENSO ODT
100%
of participants agreed TASCENSO ODT was easy to tolerate2
89%
of participants agreed they had an overall favorable opinion of TASCENSO ODT2
100%
of participants felt TASCENSO ODT left a pleasant taste2
82%
of participants agreed TASCENSO ODT had no bitter after-taste2

During a study of TASCENSO ODT
100%
of participants agreed TASCENSO ODT was easy to tolerate.2
89%
of participants agreed they had an overall favorable opinion of TASCENSO ODT.2
100%
of participants felt TASCENSO ODT left a pleasant taste.2
82%
of participants agreed TASCENSO ODT had no bitter after-taste.2

References
1. TASCENSO ODT (fingolimod). Prescribing Information. Cycle Pharmaceuticals Ltd.
2. Data on file: REF-00068.
